TRIP
50
-2
SO
50
4
SPG
50
2
MCD
42
-4
FITB
73
-5
EXR
24
-2
CINF
61
-5
SLG
31
-6
A
44
-7
KSS
56
-2
FCX
79
4
ORLY
43
2
ADP
53
-2
D
41
6
EQT
56
6
M
49
-4
AZO
48
5
UPS
37
-3
SIG
50
3
ADM
45
-2
TRIP
50
-2
SO
50
4
SPG
50
2
MCD
42
-4
FITB
73
-5
EXR
24
-2
CINF
61
-5
SLG
31
-6
A
44
-7
KSS
56
-2
FCX
79
4
ORLY
43
2
ADP
53
-2
D
41
6
EQT
56
6
M
49
-4
AZO
48
5
UPS
37
-3
SIG
50
3
ADM
45
-2
Financhill
Back

Probe Gold, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
64

PROBF
Probe Gold, Inc.

Last Price:
$2.66
Seasonality Move:
24.14%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.33
Seasonality Move:
-34.19%
Buy
64
Probe Gold, Inc. (PROBF) is a Buy

Is Probe Gold, Inc. a Buy, Sell or Hold?

  • The current Probe Gold, Inc. [PROBF] share price is $2.66. The Score for PROBF is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • PROBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PROBF Stock Price Chart

What is Probe Gold, Inc.'s stock price today?

  • The Probe Gold, Inc. share price today is $2.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PROBF is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

PROBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.65 Buy
Relative Strength Index (14 RSI): 63.58 Buy
Chaikin Money Flow: 62450 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.58 - 2.66) Buy
Bollinger Bands (100): (1.82 - 2.56) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

PROBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.65 Buy
20-day SMA: 2.63 Buy
50-day SMA: 2.46 Buy
200-day SMA: 1.87 Buy
8-day EMA: 1.89 Buy
20-day EMA: 1.04 Buy
50-day EMA: 0.48 Buy
200-day EMA: 0.13 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

Probe Gold, Inc. Earnings Growth & PROBF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Probe Gold, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):